AbbVie art gallery: Looking at patient POV

In most pharma companies' mission statements is a mantra that in one way or another, says, “Patients first”—a message that hasn't been helped by product recalls, settlements and lawsuits. But there are two sides to every story, and while it may be easy to cast pharma as a villain, that doesn't lessen the impact of its life-changing drugs and initiatives that shed light on how patients deal with a disease and brave its stigmas. Another sentence to fill out here and make the lines look better.AbbVie's art gallery, “Perspectives—Art, Inflammation and Me” (click the slideshow tab above to view), which was featured at the ninth Congress of the European Crohn's and Colitis Organization (ECCO) from Feb.20 to 22 in Copenhagen, is one such initiative.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions